Steve Morgan
Steve Morgan is an expert advisor with and Associate Professor and Associate Director of the Centre for Health Services and Policy Research at the University of British Columbia.

Entries by Steve Morgan

We Need Trudeau To Prioritize Pharmaceutical Drug Coverage

(9) Comments | Posted November 20, 2015 | 5:16 PM

Dear Prime Minister Trudeau:

Congratulations on becoming Canada's 23rd prime minister.

Over the course of the election campaign and in the weeks following your victory, there have been many important discussions about Canadian identity and our core values. Among the values that Canadians most support in poll after...

Read Post

What Trudeau Can Do To Make Medicines Accessible To All Canadians

(3) Comments | Posted November 4, 2015 | 11:50 AM

Recently the CD Howe Institute called on Ottawa to give provinces nearly $3 billion to establish national standards for catastrophic drug coverage and to mandate a system of transparent price negotiations with pharmaceutical drug manufacturers. Acting on those recommendations would represent a major step backward for Canada, one...

Read Post

Why We Need to Cover Medication for Children

(4) Comments | Posted October 17, 2015 | 9:45 AM

by Avram Denburg and Steve Morgan

You are the parent of a sick child. You have a limited budget and you must decide to buy the medicine the doctor prescribed for your child or provide food and shelter for your family instead. What do you do?

Sadly, this...

Read Post

Canadians Should Not Shoulder Prescription Drug Costs

(13) Comments | Posted May 22, 2015 | 9:10 AM

Canada's cities face a number of problems: traffic, housing, crime, infrastructure -- the list goes on. Prescription drugs are one of these problems, one that is costing local governments as much as $500 million every year.

How so? Municipalities, like most employers, realize the value of a healthy workforce....

Read Post

Universal Canadian Drug Coverage Is Good for Business

(0) Comments | Posted April 23, 2015 | 1:59 PM

Repeatedly over the past 50 years, national commissions and inquiries have recommended that Canadian medicare include universal, public coverage of prescription drugs. So far, no government has acted on this, creating profound inequities and inefficiencies in our health care system. But more than that: the lack of universal pharmacare is...

Read Post

Four Things Needed to Make Pharmacare Work for Canadians

(2) Comments | Posted February 25, 2015 | 12:52 PM

A growing number of health professionals, patients, community groups and even politicians are calling for national pharmacare. But many Canadians likely wonder what pharmacare is and whether Canada is ready for it.

Let's start at the beginning. Affordable access to safe and properly prescribed prescription medicines...

Read Post

New Brunswick's Opportunity to Reduce Pharmaceutical Drug Prices

(0) Comments | Posted December 19, 2014 | 6:12 PM

The Liberal government of New Brunswick appears to be stepping back from the brink of mandatory prescription drug insurance. And so they should.

The Conservatives had pitched the drug plan as a better model than "catastrophic" drug coverage under which people would only receive public subsidies for prescription drug costs...

Read Post

Ontario Doesn't Need An Income-Based Drug Benefit Program for Seniors

(7) Comments | Posted December 10, 2014 | 6:54 PM

Ontario spends $11-billion per year on prescription drugs. Nearly half of this is spent on medicines used by senior citizens, a group that receives public subsidies for nearly all of their prescription drug costs in Ontario.

With the population aging, seniors' entitlement to public drug coverage creates a big strain...

Read Post

The New Brunswick Drug Plan With Great Potential

(1) Comments | Posted January 7, 2014 | 4:56 PM

The Alward government has just adopted pharmacare reforms that have great potential to do good -- and great potential to cost New Brunswickers far more than it should.

The New Brunswick Drug Plan bears little resemblance to catastrophic drug plans in other provinces. That is a good thing.

All models...

Read Post

The Incoming Rise of Prescription Drug Spending

(0) Comments | Posted December 18, 2013 | 12:27 PM

Canadians spent almost $23-billion on prescription drugs at retail pharmacies in 2012/13 -- or over $650 per capita, according to the findings from the Canadian Rx Atlas published this week by the UBC Centre for Health Services and Policy Research. That is a lot of money. However, after adjusting for...

Read Post

How Canada's Pharmacare System Is Costing Us Billions

(2) Comments | Posted April 2, 2013 | 6:45 PM

Another budget cycle has passed without remedy for the biggest unresolved problem in our health care system. From 1980 to 2010, spending on pharmaceuticals used outside of hospitals in Canada grew more than 15-fold, from just under $2-billion to just over $30-billion. Yes, billion.

In contrast, spending on...

Read Post

Moving to Income-Based Drug Coverage is the Wrong Prescription for Alberta

(1) Comments | Posted March 27, 2013 | 4:38 PM

The Alberta government has announced major pharmacare reforms: the province is planning
to move from a system where public drug coverage is available mainly for seniors to a system
where coverage will be restricted based upon income. Experience from other provinces suggests
that income-based pharmacare will not...

Read Post

Canadians Are Over-Paying for Pharmaceuticals Year After Year

(4) Comments | Posted February 28, 2013 | 12:20 AM

When the topic of universal drug coverage comes up in this country, the debate often runs aground on the question of cost. In an environment of government austerity, few seem willing to embrace the idea of a new, national government program.

But a single-payer, universal system would not bankrupt the...

Read Post

Canada's Drug Patent Process Needs Rx

(0) Comments | Posted November 20, 2012 | 2:51 PM

Last week the federal government signalled that, to reach a new trade agreement with Europe, it might extend pharmaceutical patents. The move could cost Canadians up to $2 billion per year. Supporters argue that it will attract research investment and generate jobs.

But longer drug patents will...

Read Post